30900396 30182530 33737020 27580113 35633063 31140850 33569396 - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2016	1
2018	1
2019	2
2020	1
2021	2
2022	1

Page 1

Review of oncological emergencies in small animal patients.

Tumielewicz KL, Hudak D, Kim J, Hunley DW, Murphy LA. Tumielewicz KL, et al. Vet Med Sci. 2019 Aug;5(3):271-296. doi: 10.1002/vms3.164. Epub 2019 Mar 21. Vet Med Sci. 2019. PMID: 30900396 Free PMC article. Review.

Evaluation of intravenous and subcutaneous administration of a novel, excipient-free, nanoparticulate formulation of paclitaxel in dogs with spontaneously occurring neoplasia.

Selting KA, Bechtel SM, Espinosa J, Henry CJ, Tate D, Bryan JN, Rajewski L, Flesner BK, Decedue C, Baltezor M. Selting KA, et al. Vet Comp Oncol. 2018 Dec;16(4):650-657. doi: 10.1111/vco.12435. Epub 2018 Sep 4. Vet Comp Oncol. 2018. PMID: 30182530

Poly(δ-valerolactone-co-allyl-δ-valerolactone) cross-linked microparticles: Formulation, characterization and biocompatibility.

Bao Z, Jung S, Bufton J, Evans JC, Aguiar DJ, Allen C. Bao Z, et al. J Pharm Sci. 2021 Jul;110(7):2771-2777. doi: 10.1016/j.xphs.2021.03.009. Epub 2021 Mar 16. J Pharm Sci. 2021. PMID: 33737020

Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors.

Cai S, Zhang T, Forrest WC, Yang Q, Groer C, Mohr E, Aires DJ, Axiak-Bechtel SM, Flesner BK, Henry CJ, Selting KA, Tate D, Swarz JA, Bryan JN, Forrest ML. Cai S, et al. Am J Vet Res. 2016 Sep;77(9):1005-16. doi: 10.2460/ajvr.77.9.1005. Am J Vet Res. 2016. PMID: 27580113 Free PMC article. Clinical Trial.

Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017-2021).

Chae HK, Oh YI, Park S, An JH, Seo K, Kang K, Chu SN, Youn HY. Chae HK, et al. Vet Med Sci. 2022 Jul;8(4):1443-1450. doi: 10.1002/vms3.829. Epub 2022 May 27. Vet Med Sci. 2022. PMID: 35633063 Free PMC article.

Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.

Cartagena-Albertus JC, Engel Manchado J, Moise A, Moya García S, Montoya Alonso JA. Cartagena-Albertus JC, et al. Am J Vet Res. 2019 Jun;80(6):601-606. doi: 10.2460/ajvr.80.6.601. Am J Vet Res. 2019. PMID: 31140850 Free article.

Case Report: Microfragmented Adipose Tissue Drug Delivery in Canine Mesothelioma: A Case Report on Safety, Feasibility, and Clinical Findings.

Zeira O, Ghezzi E, Pettinari L, Re V, Lupi DM, Benali SL, Borgonovo S, Alessandri G, Petrella F, Paroni R, Dei Cas M, Tremolada C, Coccè V, Pessina A. Zeira O, et al. Front Vet Sci. 2021 Jan 14;7:585427. doi: 10.3389/fvets.2020.585427. eCollection 2020. Front Vet Sci. 2021. PMID: 33569396 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results